Organon & Co. (OGN) News Today $9.12 +0.43 (+4.95%) Closing price 03:59 PM EasternExtended Trading$9.18 +0.06 (+0.66%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Organon & Co. Up Today?Organon & Co. (OGN) shares are up, driven by positive regulatory news even as the company faces a wave of securities class action lawsuits. FDA grants interchangeability designation to Samsung Bioepis and Organon’s HADLIMA™ (adalimumab-bwwd) injection in both high- and low-concentration presentations, allowing pharmacists to substitute it for Humira and potentially boosting biosimilar sales. Shares carry a consensus “Hold” rating from analysts, reflecting mixed expectations for near-term performance. Numerous law firms—including Rosen Law Firm, Levi & Korsinsky, Bronstein Gewirtz & Grossman, Gainey McKenna & Egleston, Robbins Geller Rudman & Dowd, Schall Law Firm, and Kahn Swick & Foti—have filed or announced securities class action lawsuits alleging misleading disclosures between October 31, 2024 and April 30, 2025, exposing OGN to potential financial liabilities. Posted 1h agoAI Generated. May Contain Errors. OGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Rosen Law Firm Encourages Organon & Co. Investors to Inquire About Securities Class Action Investigation - OGNMay 27 at 5:33 PM | tmcnet.comOGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 27 at 4:00 PM | prnewswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Organon & Co. (OGN)May 27 at 12:23 PM | globenewswire.comUS Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMAâ„¢ (adalimumab-bwwd) InjectionMay 27 at 8:02 AM | businesswire.comOGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 27 at 5:30 AM | prnewswire.comOGN Investors Have Opportunity to Lead Organon & Co. ...May 26 at 8:45 PM | gurufocus.comOGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law FirmMay 26 at 7:42 PM | businesswire.comORGANON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGNMay 26 at 6:34 PM | businesswire.comOGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. ...May 26 at 4:04 PM | gurufocus.comOGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 26 at 3:00 PM | businesswire.comNeo Ivy Capital Management Has $326,000 Position in Organon & Co. (NYSE:OGN)Neo Ivy Capital Management reduced its stake in Organon & Co. (NYSE:OGN - Free Report) by 82.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,861 shares of the company's stock after selling 103,793May 26 at 5:35 AM | marketbeat.comMan Group plc Has $1.37 Million Stake in Organon & Co. (NYSE:OGN)Man Group plc trimmed its stake in Organon & Co. (NYSE:OGN - Free Report) by 30.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 91,792 shares of the company's stock after selling 39,645 shares during the period. MaMay 26 at 3:58 AM | marketbeat.comOrganon & Co. (NYSE:OGN) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Organon & Co. (NYSE:OGN - Free Report) by 50.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,114 shares of the company's stock after puMay 26 at 3:49 AM | marketbeat.comDeutsche Bank AG Cuts Position in Organon & Co. (NYSE:OGN)Deutsche Bank AG lowered its stake in Organon & Co. (NYSE:OGN - Free Report) by 21.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 128,092 shares of the company's stock after selling 35,745 shares during the quarter. DMay 26 at 3:30 AM | marketbeat.comOrganon & Co. (NYSE:OGN) Receives Consensus Rating of "Hold" from BrokeragesShares of Organon & Co. (NYSE:OGN - Get Free Report) have been given a consensus rating of "Hold" by the five analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendatiMay 26 at 3:07 AM | marketbeat.comOGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. ...May 25 at 4:07 PM | gurufocus.comOGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 25 at 4:00 PM | globenewswire.comOrganon & Co. (NYSE:OGN) Shares Down 4.7% - Here's WhyOrganon & Co. (NYSE:OGN) Stock Price Down 4.7% - Time to Sell?May 25 at 1:29 PM | marketbeat.comOrganon & Co. Investor Notice: Robbins LLP Reminds Investors of the Class Action Against OGNMay 25 at 9:32 AM | gurufocus.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of OrganonMay 25 at 8:49 AM | globenewswire.comOrganon & Co. Investor Notice: Robbins LLP Reminds Investors of the Class Action Against OGNMay 25 at 8:30 AM | globenewswire.comCetera Investment Advisers Purchases 29,287 Shares of Organon & Co. (NYSE:OGN)Cetera Investment Advisers boosted its position in Organon & Co. (NYSE:OGN - Free Report) by 62.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 76,005 shares of the company's stock after acquiring an additionalMay 25 at 3:29 AM | marketbeat.comBank of America Corp DE Decreases Holdings in Organon & Co. (NYSE:OGN)Bank of America Corp DE trimmed its holdings in shares of Organon & Co. (NYSE:OGN - Free Report) by 35.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 806,715 shares of the company's stock after selling 446,627May 25 at 3:19 AM | marketbeat.comOGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 24 at 10:40 AM | globenewswire.comOGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! May 24 at 4:09 AM | markets.businessinsider.comOrganon Insider Trading Activity | NYSE:OGN | BenzingaMay 24 at 1:26 AM | benzinga.comOGN Stockholder Alert: Robbins LLP Informs Investors of the Organon & Co. Class Action LawsuitMay 23, 2025 | prnewswire.comOGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead the Organon Class Action LawsuitMay 23, 2025 | prnewswire.comSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Organon & Co. Securities and Sets a Lead Plaintiff Deadline of July 22, 2025May 23, 2025 | globenewswire.comOrganon & Co. Q1 Earnings TranscriptMay 22, 2025 | marketbeat.comFocus Partners Wealth Purchases New Position in Organon & Co. (NYSE:OGN)Focus Partners Wealth purchased a new stake in shares of Organon & Co. (NYSE:OGN - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 41,950 shares of the company's stock, valued at approximately $627,000. Other institMay 22, 2025 | marketbeat.comAmeriprise Financial Inc. Reduces Holdings in Organon & Co. (NYSE:OGN)Ameriprise Financial Inc. lowered its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 15.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 737,343 shares of the company's stock after selling 137,190 shMay 21, 2025 | marketbeat.comWhy Organon & Co.’s (OGN) Surged Last WeekMay 20, 2025 | msn.comOGN INVESTIGATION: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact FirmMay 20, 2025 | prnewswire.comBNP Paribas Financial Markets Makes New $2.44 Million Investment in Organon & Co. (NYSE:OGN)BNP Paribas Financial Markets purchased a new position in Organon & Co. (NYSE:OGN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 163,713 shares of the company's stock, valued at approximatelyMay 19, 2025 | marketbeat.comGraham Capital Management L.P. Reduces Stock Position in Organon & Co. (NYSE:OGN)Graham Capital Management L.P. cut its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 64.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,105 shares of the company's stock after selling 6May 18, 2025 | marketbeat.comPiper Sandler Cuts Organon & Co. (NYSE:OGN) Price Target to $18.00May 18, 2025 | americanbankingnews.comNia Impact Advisors LLC Increases Stock Position in Organon & Co. (NYSE:OGN)Nia Impact Advisors LLC raised its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 21.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 223,157 shares of the company's stock after buying an additional 38,6May 16, 2025 | marketbeat.comKahn Brothers' Strategic Moves: Organon & Co Leads with a 2.79% Portfolio ImpactMay 16, 2025 | finance.yahoo.comLeigh Baldwin & CO. LLC Invests $344,000 in Organon & Co. (NYSE:OGN)Leigh Baldwin & CO. LLC purchased a new position in shares of Organon & Co. (NYSE:OGN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 230,699 shares of the company's stock, valued at approximately $344,May 14, 2025 | marketbeat.comOrganon & Co. (NYSE:OGN) is Kahn Brothers Group Inc.'s 9th Largest PositionKahn Brothers Group Inc. lowered its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 14.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,567,273 shares of the company's stock afterMay 13, 2025 | marketbeat.comCrestline Management LP Takes Position in Organon & Co. (NYSE:OGN)Crestline Management LP acquired a new position in Organon & Co. (NYSE:OGN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 31,045 shares of the company's stock, valued at approximately $463,000. Other large investMay 13, 2025 | marketbeat.comComerica Bank Lowers Stake in Organon & Co. (NYSE:OGN)Comerica Bank lessened its holdings in Organon & Co. (NYSE:OGN - Free Report) by 45.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,735 shares of the company's stock after selling 94,6May 13, 2025 | marketbeat.comNorthern Trust Corp Buys 290,134 Shares of Organon & Co. (NYSE:OGN)Northern Trust Corp raised its stake in Organon & Co. (NYSE:OGN - Free Report) by 17.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,914,115 shares of the company's stock after purchasing an additionalMay 13, 2025 | marketbeat.comOrganon & Co: Cost Takeout Catalysts, Initiate Strong BuyMay 12, 2025 | seekingalpha.comOGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. ...May 11, 2025 | gurufocus.comSchonfeld Strategic Advisors LLC Boosts Stake in Organon & Co. (NYSE:OGN)Schonfeld Strategic Advisors LLC raised its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 195.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,669 shares of the company's stock after acquiMay 11, 2025 | marketbeat.comOGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law FirmMay 10, 2025 | prnewswire.comDeprince Race & Zollo Inc. Has $70.56 Million Stock Holdings in Organon & Co. (NYSE:OGN)Deprince Race & Zollo Inc. boosted its position in Organon & Co. (NYSE:OGN - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,729,258 shares of the company's stock after purchasing an addiMay 10, 2025 | marketbeat.comCEO & Director of Organon Picks Up 14% More StockMay 9, 2025 | finance.yahoo.com Get Organon & Co. News Delivered to You Automatically Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter. Email Address OGN Media Mentions By Week OGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OGN News Sentiment▼0.341.02▲Average Medical News Sentiment OGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OGN Articles This Week▼307▲OGN Articles Average Week Get Organon & Co. News Delivered to You Automatically Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ROIV News RVMD News ELAN News BPMC News BBIO News VRNA News TLX News TGTX News GRFS News LNTH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OGN) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OGN Stock Free OGN Stock Alerts